blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2604620

EP2604620 - Modified fluorinated nucleoside analogues [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  17.05.2024
Database last updated on 11.11.2024
Most recent event   Tooltip19.09.2024Correction of patent specificationpublished on 23.10.2024  [2024/43]
Applicant(s)For all designated states
Gilead Pharmasset LLC
c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404 / US
[2024/25]
Former [2013/25]For all designated states
Gilead Pharmasset LLC
c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404 / US
Inventor(s)01 / Clark, Jeremy
2883 Quinbery Drive
Snellville, GA 30039 / US
 [2016/20]
Former [2013/25]01 / Clark, Jeremy
2883 Quinbery Drive
Snellville, GA Georgia 30039 / US
Representative(s)Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[2024/25]
Former [2016/26]Wallace, Sheila Jane, et al
Marks & Clerk LLP
90 Long Acre
London WC2E 9RA / GB
Former [2014/27]Wallace, Sheila Jane, et al
Marks & Clerk LLP 90 Long Acre London
WC2E 9RA / GB
Former [2013/25]Walker, Ross Thomson
Forresters
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
Application number, filing date13152340.921.04.2004
[2013/25]
Priority number, dateUS20030474368P30.05.2003         Original published format: US 474368 P
[2013/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2604620
Date:19.06.2013
Language:EN
[2013/25]
Type: B1 Patent specification 
No.:EP2604620
Date:29.06.2016
Language:EN
[2016/26]
Type: B2 New European patent specification 
No.:EP2604620
Date:19.06.2024
Language:EN
[2024/25]
Type: B9 Corrected patent specification 
No.:EP2604620
Date:23.10.2024
[2024/43]
Search report(s)(Supplementary) European search report - dispatched on:EP16.05.2013
ClassificationIPC:C07H19/06, C07H19/10, A61K31/7068, A61P31/14
[2013/25]
CPC:
C07H19/00 (EP,KR,US); A61K31/7068 (EP,US); A61K31/7072 (EP,US);
A61P1/16 (EP); A61P31/00 (EP); A61P31/04 (EP);
A61P31/12 (EP); A61P31/14 (EP); A61P31/16 (EP);
A61P35/00 (EP); A61P43/00 (EP); C07H19/04 (EP,US);
C07H19/048 (EP,US); C07H19/06 (EP,KR,US); C07H19/14 (EP,KR,US);
C07H19/16 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/26]
Former [2013/25]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesHR18.12.2013
LT18.12.2013
LV18.12.2013
TitleGerman:Modifizierte fluorinierte Nukleosidanaloga[2013/25]
English:Modified fluorinated nucleoside analogues[2013/25]
French:Analogues de nucléosides fluorés modifiés[2013/25]
Examination procedure18.12.2013Amendment by applicant (claims and/or description)
18.12.2013Examination requested  [2014/05]
20.12.2013Observations by third parties
07.04.2014Observations by third parties
09.06.2015Despatch of a communication from the examining division (Time limit: M06)
16.10.2015Observations by third parties
21.12.2015Reply to a communication from the examining division
20.04.2016Communication of intention to grant the patent
22.04.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
22.04.2016Fee for grant paid
22.04.2016Fee for publishing/printing paid
19.05.2016Information about intention to grant a patent
19.05.2016Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP04775900.6  / EP1633766
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040775900) is  24.01.2011
Opposition(s)Opponent(s)01  27.03.2017  18.04.2017  ADMISSIBLE
Medici Senza Frontiere Onlus et al
Via Magenta, 5
00185 Roma / IT
Opponent's representative
Jorget, Quentin
J-INVENT
110, rue Vieille du Temple
75003 Paris / FR
 02  27.03.2017  18.04.2017  ADMISSIBLE
Médecins du Monde et al
62 rue Marcadet
75018 Paris / FR
Opponent's representative
Jorget, Quentin
J-INVENT
110, rue Vieille du Temple
75003 Paris / FR
 03  27.03.2017  18.04.2017  ADMISSIBLE
AIDES
14 rue Scandicci
93508 Pantin Cedex / FR
Opponent's representative
Jorget, Quentin
J-INVENT
110, rue Vieille du Temple
75003 Paris / FR
 04  29.03.2017  18.04.2017  ADMISSIBLE
Gillard, Richard Edward
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 [2023/29]
Former [2023/27]
Opponent(s)01  27.03.2017  18.04.2017  ADMISSIBLE
Medici Senza Frontiere Onlus et al
Via Magenta, 5
00185 Roma / IT
 02  27.03.2017  18.04.2017  ADMISSIBLE
Médecins du Monde et al
62 rue Marcadet
75018 Paris / FR
Opponent's representative
Jorget, Quentin
J-INVENT
110, rue Vieille du Temple
75003 Paris / FR
 03  27.03.2017  18.04.2017  ADMISSIBLE
AIDES
14 rue Scandicci
93508 Pantin Cedex / FR
Opponent's representative
Jorget, Quentin
J-INVENT
110, rue Vieille du Temple
75003 Paris / FR
 04  29.03.2017  18.04.2017  ADMISSIBLE
Gillard, Richard Edward
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
Former [2023/20]
Opponent(s)01  27.03.2017  18.04.2017  ADMISSIBLE
Medici Senza Frontiere Onlus et al
Via Magenta, 5
00185 Roma / IT
 02  27.03.2017  18.04.2017  ADMISSIBLE
Médecins du Monde et al
62 rue Marcadet
75018 Paris / FR
Opponent's representative
Jorget, Quentin
J-INVENT
110, rue Vieille du Temple
75003 Paris / FR
 03  27.03.2017  18.04.2017  ADMISSIBLE
AIDES
14 rue Scandicci
93508 Pantin Cedex / FR
 04  29.03.2017  18.04.2017  ADMISSIBLE
Gillard, Richard Edward
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
Former [2022/31]
Opponent(s)01  27.03.2017  18.04.2017  ADMISSIBLE
Medici Senza Frontiere Onlus et al
Via Magenta, 5
00185 Roma / IT
 02  27.03.2017  18.04.2017  ADMISSIBLE
Médecins du Monde et al
62 rue Marcadet
75018 Paris / FR
 03  27.03.2017  18.04.2017  ADMISSIBLE
AIDES
14 rue Scandicci
93508 Pantin Cedex / FR
 04  29.03.2017  18.04.2017  ADMISSIBLE
Gillard, Richard Edward
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
Former [2021/26]
Opponent(s)01  27.03.2017  18.04.2017  ADMISSIBLE
Medici Senza Frontiere Onlus et al
Via Magenta, 5
00185 Roma / IT
 02  27.03.2017  18.04.2017  ADMISSIBLE
Médecins du Monde et al
62 rue Marcadet
75018 Paris / FR
 03  27.03.2017  18.04.2017  ADMISSIBLE
European Public Health Alliance (EPHA) et al
Rue de Trèves 49-51
1040 Brussels / BE
 04  29.03.2017  18.04.2017  ADMISSIBLE
Gillard, Richard Edward
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
Former [2019/11]
Opponent(s)01  27.03.2017  18.04.2017  ADMISSIBLE
Medici Senza Frontiere Onlus et al
Via Magenta, 5
00185 Roma / IT
Opponent's representative
Vial, Lionel
Cabinet Lionel Vial
2 rue Jean Rostand
91400 Orsay / FR
 02  27.03.2017  18.04.2017  ADMISSIBLE
Médecins du Monde et al
62 rue Marcadet
75018 Paris / FR
Opponent's representative
Vial, Lionel
Cabinet Lionel Vial
2 rue Jean Rostand
91400 Orsay / FR
 03  27.03.2017  18.04.2017  ADMISSIBLE
European Public Health Alliance (EPHA) et al
Rue de Trèves 49-51
1040 Brussels / BE
Opponent's representative
Vial, Lionel
Cabinet Lionel Vial
2 rue Jean Rostand
91400 Orsay / FR
 04  29.03.2017  18.04.2017  ADMISSIBLE
Gillard, Richard Edward
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
Opponent's representative
Elkington & Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
Former [2018/52]
Opponent(s)01  27.03.2017  18.04.2017  ADMISSIBLE
Medici Senza Frontiere Onlus et al
Via Magenta, 5
00185 Roma / IT
Opponent's representative
Vial, Lionel
Cabinet Lionel Vial
6 rue de Vaugondran
91190 Gif-sur-Yvette / FR
 02  27.03.2017  18.04.2017  ADMISSIBLE
Médecins du Monde et al
62 rue Marcadet
75018 Paris / FR
Opponent's representative
Vial, Lionel
Cabinet Lionel Vial
6 rue de Vaugondran
91190 Gif-sur-Yvette / FR
 03  27.03.2017  18.04.2017  ADMISSIBLE
European Public Health Alliance (EPHA) et al
Rue de Trèves 49-51
1040 Brussels / BE
Opponent's representative
Vial, Lionel
Cabinet Lionel Vial
6 rue de Vaugondran
91190 Gif-sur-Yvette / FR
 04  29.03.2017  18.04.2017  ADMISSIBLE
Gillard, Richard Edward
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
Opponent's representative
Elkington & Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
Former [2017/21]
Opponent(s)01  27.03.2017  18.04.2017  ADMISSIBLE
Medici Senza Frontiere Onlus et al
Via Magenta, 5
00185 Roma / IT
Opponent's representative
Vial, Lionel
Cabinet Lionel Vial
6 rue de Vaugondran
91190 Gif-sur-Yvette / FR
 02  27.03.2017  18.04.2017  ADMISSIBLE
Médecins du Monde et al
62 rue Marcadet
75018 Paris / FR
Opponent's representative
Vial, Lionel
Cabinet Lionel Vial
6 rue de Vaugondran
91190 Gif-sur-Yvette / FR
 03  27.03.2017  18.04.2017  ADMISSIBLE
European Public Health Alliance (EPHA) et al
Rue de Trèves 49-51
1040 Brussels / BE
Opponent's representative
Vial, Lionel
Cabinet Lionel Vial
6 rue de Vaugondran
91190 Gif-sur-Yvette / FR
 04  29.03.2017  18.04.2017  ADMISSIBLE
Gillard, Richard Edward
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
Opponent's representative
Gillard, Richard Edward
Elkington and Fife LLP
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
Former [2017/20]
Opponent(s)01  27.03.2017   
Medici Senza Frontiere Onlus et al
Via Magenta, 5
00185 Roma / IT
Opponent's representative
Vial, Lionel
Cabinet Lionel Vial
6 rue de Vaugondran
91190 Gif-sur-Yvette / FR
 02  27.03.2017   
Médecins du Monde et al
62 rue Marcadet
75018 Paris / FR
Opponent's representative
Vial, Lionel
Cabinet Lionel Vial
6 rue de Vaugondran
91190 Gif-sur-Yvette / FR
 03  27.03.2017   
European Public Health Alliance (EPHA) et al
Rue de Trèves 49-51
1040 Brussels / BE
Opponent's representative
Vial, Lionel
Cabinet Lionel Vial
6 rue de Vaugondran
91190 Gif-sur-Yvette / FR
23.05.2017Invitation to proprietor to file observations on the notice of opposition
29.09.2017Reply of patent proprietor to notice(s) of opposition
13.09.2018Date of oral proceedings
02.10.2018Despatch of interlocutory decision in opposition
02.10.2018Despatch of minutes of oral proceedings
12.09.2023Legal effect of interlocutory decision in opposition
29.01.2024Despatch of communication that the patent will be maintained as amended
Appeal following opposition01.12.2018Appeal received No.  T2887/18
12.02.2019Statement of grounds filed
12.09.2023Result of appeal procedure: appeal of the opponent was rejected
04.12.2023Despatch of the decision of the Board of Appeal
01.12.2018Appeal received No.  T2887/18
11.02.2019Statement of grounds filed
12.09.2023Result of appeal procedure: appeal of the opponent was rejected
04.12.2023Despatch of the decision of the Board of Appeal
12.09.2023Date of oral proceedings
Fees paidRenewal fee
23.01.2013Renewal fee patent year 03
23.01.2013Renewal fee patent year 04
23.01.2013Renewal fee patent year 05
23.01.2013Renewal fee patent year 06
23.01.2013Renewal fee patent year 07
23.01.2013Renewal fee patent year 08
23.01.2013Renewal fee patent year 09
29.04.2013Renewal fee patent year 10
28.04.2014Renewal fee patent year 11
27.04.2015Renewal fee patent year 12
27.04.2016Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipGB20.04.2024
CZ21.04.2024
IE21.04.2024
SK21.04.2024
ES22.04.2024
SI22.04.2024
PT03.05.2024
[2024/36]
Former [2024/35]GB20.04.2024
CZ21.04.2024
IE21.04.2024
ES22.04.2024
SI22.04.2024
Former [2024/33]GB20.04.2024
IE21.04.2024
SI22.04.2024
Former [2024/24]SI22.04.2024
Documents cited:Search[AD]WO0190121  (NOVIRIO PHARMACEUTICALS LTD [KY], et al);
 [XP]WO2004002999  (IDENIX CAYMAN LTD [KY], et al)
by applicantUS3798209
 USRE29835E
 DE3512781
 EP0180276
 WO8902733
 EP0350287
 WO9000555
 US4957924
 US5026687
 WO9116920
 WO9118914
 WO9119721
 US5149794
 US5157027
 WO9300910
 US5194654
 US5223263
 US5256641
 WO9426273
 US5372808
 US5411947
 WO9513090
 US5463092
 US5496546
 WO9615132
 US5538865
 US5543389
 US5543390
 US5543391
 US5554728
 JPH08268890
 US5610054
 WO9712033
 US5633358
 US5633388
 WO9736554
 US5676942
 US5711944
 US5725859
 US5738845
 US5738846
 JPH10101591
 WO9817679
 US5747646
 WO9822496
 US5792834
 US5830455
 US5830905
 US5834594
 US5837257
 US5846964
 US5849696
 US5869253
 WO9907734
 WO9915194
 US5891874
 US5908621
 WO9932139
 WO9932140
 US5922757
 US5928636
 US5942223
 WO9943691
 DE19914474
 US5980884
 US5990276
 WO9959621
 WO9964016
 US6004933
 WO0009531
 US6034134
 US6043077
 US6056961
 WO0024355
 WO0037110
 WO0132153
 WO0160315
 WO0179246
 WO0181359
 WO0190121
 WO0192282
 WO0196353
 WO0208251
 WO0208187
 WO0208256
 WO0208198
 US6348587
 WO0218404
 WO0232414
 WO0232920
 WO0248172
 WO0248157
 WO0248116
 WO0248165
 US6410531
 US6420380
 WO02057425
 WO02057287
 WO02060926
 US6534523
 WO03024461
 WO03105770
 WO2004002422
 WO2004002999
 WO2004007512
 WO2004009020
 EP19930917054
otherWO2004002999
OppositionWO0192282
 WO02057425
 WO2004002999
 WO2005003147
 WO0190121
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.